Meanwhile, NO could activate sGC in vascular smooth muscle cells, and the activated sGC could catalyze the conversion of GTP into cGMP to activate cGMP-dependent protein kinase (PKG) [43], leading to vasodilation, thereby improving pulmonary hypertension. This evidence concerns the gene PRKG1 and pulmonary hypertension.